Photo: Baiya’s co-founder via baiyaphytopharm.com
Thai pharmaceutical firm Baiya Phytopharm has successfully developed anti-cancer antibodies derived from tobacco plants, marking a breakthrough in plant-based immunotherapy for oncology. The company, operating under Chulalongkorn University, conducted successful trials on lab animals and received the Research of the Year 2023 title from the National Research Council of Thailand. Baiya Phytopharm aims to reduce the cost of cancer treatment drugs in Thailand and make plant-based immunotherapy more accessible. Unlike chemotherapy, plant-based immunotherapy enhances immune cells to inhibit the growth of cancer cells. The biotechnology team used Nicotiana benthamiana, an Australian species, to produce the antibodies.
Meta Data: {“keywords”:”Baiya Phytopharm, plant-based immunotherapy, anti-cancer antibodies”}
Source link